1 active not recruiting, 1 completed. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance Giapreza - Septic Shock, Cirrhosis | Early Phase 1 | Active not recruiting | The Cleveland Clinic | 30 | 2024-11-15 | 2026-05-05 |
| Dose-response Study of Arginine Supplementation in Severe Sepsis L-arginine - Sepsis, Septic Shock | Early Phase 1 | Completed | Maastricht University Medical Center | 8 | 2003-10-01 | 2013-01-29 |
Shock, Septic (2) · Acute Kidney Injury (1) · Fibrosis (1) · Sepsis (1)
Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Shock (2) · Systemic Inflammatory Response Syndrome (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Renal Insufficiency (1) · Sepsis (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Arginine (1) · Giapreza (1) · angiotensin II, Phe(4)- (1)
Maastricht University Medical Center (1) · The Cleveland Clinic (1)
United States (1)